Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAT | ABUS | OCGN | ||
| Company | Phathom Pharmaceuticals Inc | Arbutus Biopharma Corp | Ocugen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.56 | 4.30 | 2.51 | ||
| High | 11.00 | 4.41 | 2.67 | ||
| Low | 10.33 | 4.24 | 2.31 | ||
| Latest | 10.44 | 4.36 | 2.33 | ||
| Change | +0.07 | +0.10 | -0.15 | ||
| % Change | +0.68% | +2.35% | -6.05% | ||
| Volume | 1,395,300 | 1,780,800 | 11,827,801 | ||
| 20-Day Average Volume | 1,174,200 | 2,860,755 | 9,590,855 | ||
| Previous Close | 10.37 | 4.26 | 2.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.44 | 4.50 | 1.85 | ||
| 20-Day Raw Stochastic | 9.51% | 46.93% | 73.64% | ||
| 20-Day Relative Strength | 38.50 | 48.38 | 65.24 | ||
| Weighted Alpha | +3.73 | +29.85 | +133.20 | ||
| Today's Opinion | 72% Sell | 40% Buy | 100% Buy | ||
| Previous Opinion | 72% Sell | 24% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 24% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.03% since 03/09/26 | -7.63% since 03/09/26 | +40.36% since 03/09/26 | ||
| Low | 10.02 on 03/12/26 | 4.20 on 03/12/26 | 1.67 on 03/10/26 | ||
| High | 11.77 on 03/10/26 | 4.85 on 03/10/26 | 2.67 on 03/16/26 | ||
| 1-Month | |||||
| %Chg | -13.14% since 02/13/26 | +9.55% since 02/13/26 | +65.25% since 02/13/26 | ||
| Low | 10.02 on 03/12/26 | 3.93 on 02/17/26 | 1.38 on 02/17/26 | ||
| High | 14.39 on 02/26/26 | 4.85 on 03/10/26 | 2.67 on 03/16/26 | ||
| 3-Month | |||||
| %Chg | -31.50% since 12/16/25 | -5.01% since 12/16/25 | +57.43% since 12/16/25 | ||
| Low | 10.02 on 03/12/26 | 3.50 on 02/02/26 | 1.31 on 02/09/26 | ||
| High | 18.31 on 12/23/25 | 5.05 on 12/31/25 | 2.67 on 03/16/26 | ||
| 6-Month | |||||
| %Chg | -4.92% since 09/16/25 | -0.91% since 09/16/25 | +99.15% since 09/16/25 | ||
| Low | 10.02 on 03/12/26 | 3.50 on 02/02/26 | 1.09 on 11/21/25 | ||
| High | 18.31 on 12/23/25 | 5.07 on 12/15/25 | 2.67 on 03/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 817,146 | 819,300 | 813,185 | ||
| Shares Outstanding, K | 78,799 | 192,324 | 327,897 | ||
| Annual Sales | 175,110,000 | 6,170,000 | 4,410,000 | ||
| Annual Net Income | -221,250,000 | -69,920,000 | -67,850,000 | ||
| Last Quarter Sales | 57,580,000 | 530,000 | 1,750,000 | ||
| Last Quarter Net Income | -21,150,000 | -7,740,000 | -20,050,000 | ||
| 60-Month Beta | 0.51 | 0.69 | 2.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 10/30/25 | -0.04 on 11/13/25 | -0.07 on 11/05/25 | ||
| Latest Earnings Date | 05/07/26 | 03/26/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||